SpringerProtocols: Abstract: Antisense Inhibition of the Renin-Angiotensin System

Antisense Inhibition of the Renin-Angiotensin System

By: Dagmara Mohuczy², M. Ian Phillips²

Abstract

Full Text

Download PDF (158K)

Antisense inhibition has been developed, particularly in cell-culture applications, to the point where it is being tested in clinical trials for HIV and cancer (1,2). The pros and cons of its use have been reviewed elsewhere (3). Before 1992, however, antisense (AS) had not been applied in vivo with any success. There was much concern about the efficiency of cellular uptake of oliogodeoxynucleotides (ODNs). During 1992-1993, a few laboratories simultaneously and independently designed AS-ODNs and tested them in the brain (4-8). Cellular uptake was not a limiting factor in the central nervous system.

Affiliation(s): (2) Department of Physiology, College of Medicine, University of Florida, Gainesville, FL

Book Title: Angiotensin Protocols

Series: Methods in Molecular Medicine | Volume: 51 | Pub. Date: Oct-29-2000 | Page Range: 83-104 | DOI: 10.1385/1-59259-087-X:83

Subject: Molecular Medicine

References

Download References

1.	Wagner, R. W. (1994) Gene inhibition using antisense oligodeoxynucleotides. Nature 372, 333–335.

2.	Crooke, S. T. (1992) Therapeutic applications of oligonucleotides. Annu. Rev. Pharmacol. Toxicol. 32, 329–376.

3.	Stein, C. A. and Cheng, Y.-C. (1993) Antisense oligonucleotides: is the bullet really magical? Science 261, 1004–1012.

4.	Chiasson, B. J., Hooper, M. L., Murphy, P. R., and Robertson, H. A. (1992) Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain. Eur. J. Pharmacol. 277, 451–453.

5.	Wahlestedt, C., Pich, E. M., Koob, G. F., Yee, F., and Heilig, M. (1993) Modulation of anxiety andneuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science 259, 528–531.

6.	Wahlestedt, C., Golanov, E., Yamamoto, S., Yee, F., Ericson, H., Yoo, H., et al. (1993) Antisense oligonucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischemic infarctions. Nature 363, 260–263.

7.	McCarthy, M. M., Masters, D. B., Rimvall, K., Schwartz-Giblin, S., and Pfaff, D. W. (1994) Intracerebral administration of antisense oligodeoxynucleotides to GAD65 and GAD67 mRNAs modulates reproductive behavior in the female rat. Brain Res. 636, 209–220. <Occurrence Type="DOI"><Handle>10.1016/0006-8993(94)91019-7</Handle></Occurrence>

8.	Gyurko, R., Wielbo, D., and Phillips, M. I. (1993) Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Regul. Pept. 49, 167–174. <Occurrence Type="DOI"><Handle>10.1016/0167-0115(93)90438-E</Handle></Occurrence>

9.	Phillips, M. I. (1997) Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension. Hypertension 29, 177–187.

10.	Junemaitre, X., Soubrier, F., Kotelvtsev, Y. V., Lifton, R. P., Williams, C. S., Charru, A., et al. (1992) Molecular basis of human hypertension: role of angiotensinogen. Cell 71, 169–180. <Occurrence Type="DOI"><Handle>10.1016/0092-8674(92)90275-H</Handle></Occurrence>

11.	Kim, H. S., Krege, J. H., Kluckman, K. D., Hagaman, J. R., Hodgin, J. B., Best, C. F., et al. (1995) Genetic control of blood pressure and the angiotensinogen locus. Proc. Natl. Acad. Sci. 92, 2735–2739.

12.	Tanimoto, K., Sugiyama, F., Goto, Y., Ishida, J., Takimoto, E., Yagami, K., et al. (1994) Angiotensinogen-deficient mice with hypotension. J. Biol. Chem. 269, 31,334–31,337.

13.	Phillips, M. I., Mann, J. F. E., Haebara, H., Hoffman, W. E., Dietz, R., Schelling, P., and Ganten, D. (1977) Lowering of hypertension by central saralasin in the absence of plasma renin. Nature 270, 445–447.

14.	Nazarali, A. J., Gutkind, J. S., Correa, F. M., and Saavedra, J. M. Decreased angiotensin II receptors in subfornical organ of spontaneously hypertensive rats after chronic antihypertensive treatment with enalapril. Am. J. Hyperten. 3, 59–61.

15.	Phillips, M. I. and Kimura, B. (1988) Brain angiotensin in the developing spontaneously hypertensive rat. J. Hypertens. 6, 607–612.

16.	Simons, R. W. (1998) Naturally occurring antisense RNA control-a brief review. Gene 72, 35–44. <Occurrence Type="DOI"><Handle>10.1016/0378-1119(88)90125-4</Handle></Occurrence>

17.	Campbell, J. M., Bacon, T. A., and Wickstrom, E. (1990) Oligodeoxynucleotide phosphorothioate stability in subcellular extracts, culture media, ser and cerebrospinal fluid. J. Biochem. Biophys. Methods 20, 259–267. <Occurrence Type="DOI"><Handle>10.1016/0165-022X(90)90084-P</Handle></Occurrence>

18.	Li, B., Hughes, J. A., and Phillips, M. I. (1997) Uptake and efflux of intact antisense phosphorthioate deoxyoligonucleotide directed against angiotensin receptors in bovine adrenal cells. Neurochem. Int. 31, 393–403. <Occurrence Type="DOI"><Handle>10.1016/S0197-0186(96)00109-X</Handle></Occurrence>

19.	Iversen, P. L., Zhu, S., Meyer, A., and Zon, G. (1992) Cellular uptake and subcellular distribution of phosphorothioate oligonucleotides into cultured cells. Antisense Res. Dev. 2, 211–222.

20.	Loke, S. L., Stein, C. A., Zhang, X. H., Mori, K., Nakanishi, M., Subasinghe, C., et al. (1989) Characterization of oligonucleotide transport into living cells. Proc. Natl. Acad. Sci. USA 86, 3474–3478.

21.	Wagner, R. W., Matteucci, M. D., Lewis, J. G., Gutierrez, A. J., Moulds, C., and Froehler, B. C. (1993) Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines. Science 260, 1510–1513.

22.	Iversen, P. L., Mata, J., Tracewell, W. G., and Zon, G. (1994) Pharmacokinetics of an antisense phosphorothioate oligodeoxynucleotide against rev from human immunodeficiency virus type 1 in the adult male rat following single injections and continuous infusion. Antisense Res. Dev. 4, 43–52.

23.	Phillips, M. I., Wielbo, D., and Gyurko, R. (1994) Antisense inhibition of hypertension: a new strategy for renin-angiotensin candidate genes. Kidney Int. 46, 1554–1556.

24.	Ambuehl, P., Gyurko, R., and Phillips, M. I. (1995) A decrease of angiotensin receptor number in rat brain nuclei by antisense oligonucleotides against the angiotensin AT_1A receptor. Regul. Pept. 59, 171–182. <Occurrence Type="DOI"><Handle>10.1016/0167-0115(95)00092-P</Handle></Occurrence>

25.	Wielbo, D., Sernia, C., Gyurko, R., and Phillips, M. I. (1995) Antisense inhibition of hypertension in the spontaneously hypertensive rat. Hypertension 25, 314–319.

26.	Morishita, R., Gibbons, G. H., Kaneda, Y., Ogihara, T., and Dzau, V. J. (1994) Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery. Gene 149, 13–19. <Occurrence Type="DOI"><Handle>10.1016/0378-1119(94)90406-5</Handle></Occurrence>

27.	Colige, A., Sokolov, B. P., Nugent, P., Baserge, R., and Prockop, D. J. (1993) Use of an antisense oligonucleotide to inhibit expression of a mutated human pro-collagen gene (COL1A1) in transfected mouse 3T3 cells. Biochemistry 32, 7–11.

28.	Tomita, N., Morishita, R., Higaki, J., Kaneda, Y., Mikami, H., and Ogihara, T. (1994) In vivo transfer of antisense oligonucleotide against rat angiotensinogen with HVJ-liposome delivery resulted in reduction of blood pressure in SHR. Hypertension 24, 397.

29.	Wielbo, D., Simon, A., Phillips, M. I., and Toffolo, S. (1996) Inhibition of hypertension by peripheral administration of antisense oligodeoxynucleotides. Hypertension 28, 147–151.

30.	Mohuczy, D., Tang, X. P., Kimura, B., and Phillips, M. I. (1999) Adeno-associated virus-based vector with angiotensinogen cDNA is effective in rat hepatoma cells. FASEB J. 13, A484 (abstr.).

31.	Tang, X. P., Mohuczy, D., Zhang, Y., Kimura, B., Galli, S. M., and Phillips, M. I. (1999) Intravenous angiotensinogen antisense in AAV-based vctor decreases hypertension. Am. J. Physiol. 277 (Heart Circ. Physiol. 46), H2392–H2399.

32.	Mulligan, R. C. (1993) The basic science of gene therapy. Science 260, 926–932.

33.	Iyer, S. N., Lu, D., Katovich, M. J., and Raizada, M. K. (1996) Chronic control of high blood pressure in spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense. Proc. Natl. Acad. Sci. USA 93, 9960–9965.

34.	Brody, S. L., Jaffe, H. A., Eissa, N. T., and Daniel, C. (1994) Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8, 42–51.

35.	Quantin, B., Perricaudet, L. D., Tajbakhsh, S., and Mandel, J.-L. (1992) Adenovirus as an expression vector in muscle cells in vivo. Proc. Natl. Acad. Sci USA 89, 2581–2584.

36.	Le Gal La Salle, G., Robert, J. J., Berrard, S., Ridoux, V., Stratford-Perricaudet, L. D., Perricaudet, M., and Mallet, J. (1993) An adenovirus vector for gene transfer into the neurons and glia in the brain. Science 259, 988–990.

37.	Lu, D., Yang, H., and Raizada, M. K. (1998) Attenuation of Ang II actions by adenovirus delivery of AT₁ receptor antisense in neurons and SMC. Am. J. Physiol. 274, H719–H727.

38.	Burcin, M. M., Schiedner, G., Kochanek, S., Tsai, S. Y., and O’Malley, B. W. (1999) Adenovirus-mediated regulable target gene expression in vivo. Proc. Natl. Acad. Sci. USA 96, 355–360.

39.	Kochanek, S., Clemens, P. R., Mitani, K., Chen, H. H., Chan, S., and Caskey, C. T. (1996) A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc. Natl. Acad. Sci. USA 93, 5731–5736.

40.	Muzyczka, N. and McLaughin, S. (1988) Use of adeno-associated virus as a mammalian transduction vector, in Current Communications in Molecular Biology: Viral Vectors (Gluzman, Y. and Hughes, S. H., eds.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 39–44.

41.	Ponnazhagan, S., Nallari, M. L., and Srivastava, A. (1994) Suppression of human a-globin gene expression mediated by the recombinant adeno-associated virus 2-based antisense vectors. J. Exp. Med. 179, 733–738.

42.	Chatterjee, S., Johnson, P. R., and Wong, K. K. (1992) Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector. Science 258, 1485–1488.

43.	Muzyczka, N. (1992) Use of adeno-associated virus as a general transduction vector for mammalian cells, in Current Topics in Microbiology and Immunology, vol. 158, Springer-Verlag, Berlin, pp. 97–129.

44.	Samulski, R. J., Zhu, X., Xiao, X., Brook, J. D., Housman, D. E., Epstein, N., and Hunter, L. A. (1991) Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10, 3941–3950.

45.	Linden, R. M., Winocour, E., and Berns, K. I. (1996) The recombination signals for adeno-associated virus site-specific integration. Proc. Natl. Acad. Sci. USA 93, 7966–7972.

46.	Lebkowski, J. S., McNally, M. M., Okarma, T. B., and Lerch, B. (1988) Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types. Mol. Cell. Biol. 8, 3988–3996.

47.	Flotte, T. R., Carter, B., Conrad, C., Guggino, W., Reynolds, T., Rosenstein, B., et al. (1996) A phase I study of an adeno-associated virus-CTFR gene vector in adult CF patients with mild lung disease. Hum. Gene Ther. 7, 1145–1159.

48.	Bennett, C. F., Condon, T. P., Grimm, S., Chan, H., and Chiang, M. Y. (1994) Inhibition of endothelial cell adhesion molecule expression with antisense oligo-nucleotides. J. Immunol. 152, 3530–3540.

49.	Bacon, T. A. and Wickstrom, E. (1991) Walking along human c-myc mRNA with antisense oligonucleotides: maximum efficacy at the 5′ cap region. Oncogene Res. 6, 13–19.

50.	Cowsert, L. M., Fox, M. C., Zon, G., and Mirabelli, C. K. (1993) In vitro evaluation of phosphorothioate oligonucleotides targeted to the E2 mRNA of papillomavirus: potential treatment for genital warts. Antimicrob. Agents Chemother. 37, 171–177.

51.	Lima, W. F., Monia, B. P., Ecker, D. J., and Freier, S. M. (1992) Implication of RNA structure on antisense oligonucleotide hybridization kinetics. Biochemistry 31, 12,055–12,061.

52.	Sczakiel, G., Homann, K., and Rittner, K. (1993) Computer-aided search for effective antisense RNA target sequences of the human immunodeficiency virus type 1. Antisense Res. Dev. 3, 45–52.

53.	Jaroszewski, J. W., Syi, J. L., Ghosh, M., Ghosh, K., and Cohen, J. S. (1993) Targeting of antisense DNA: comparison of activity of anti-rabbit beta-globin oligodeoxyribonucleoside phosphorothioates with computer predictions of mRNA folding. Antisense Res. Dev. 3, 339–348.

54.	Gyurko, R. and Phillips, M. I. (1995) Antisense expression vector decreases angiotensin receptor binding in NG108-15 cells. Exp. Biol. #1915 (abstr.).

55.	Gyurko, R., Wu, P., Sernia, C., Meyer, E., and Phillips, M. I. (1994) Antisense expression vector decreases angiotensinogen synthesis in H-4 hepatoma cells. American Heart Assoc. 48th Ann. Council for High Blood Pressure, (abstr.).

56.	Zolotukhin, S., Potter, M., Hauswirth, W. W., Guy, J., and Muzyczka, N. (1996) A “humanized“ green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J. Virol. 70, 4646–4654.

57.	Wu, P., Du, B., Phillips, M. I., Bui, J., and Terwilliger, E. F. Adeno-associated viral vector mediated transgene integration in non-dividing cells. J. Virol. 72, 5919–5926.

58.	Mohuczy, D. and Phillips, M. I. (1996) Adeno-associated virus vector as a highly efficient transporter of exogenous DNA into cells. FASEB J. 10, A447 (abstr.).

59.	Zelles, T., Mohuczy, D., and Phillips, M. I. (1996) Inhibition of angiotensin receptor (AT₁) expression in NG108-15 cells transfected with AT₁ receptor antisense in an adeno-associated viral vector. Soc. Neurosci. #41.18, 83 (abstr.).

60.	Mohuczy, D., Gelband, C., and Phillips, M. I. (1999) Antisense inhibition of AT1 receptor in vascular smooth muscle cells using adeno-associated virus-based vector. Hypertension 33, 354–359.

61.	Phillips, M. I., Mohuczy-Dominiak, D., Coffey, M., Wu, P., Galli, S. M., and Zelles, T. (1997) Prolonged reduction of high blood pressure with an in vivo, nonpathogenic, adeno-associated viral vector delivery of AT1_-R mRNA antisense. Hypertension 29, 374–380.

62.	Kimura, B., Mohuczy, D., and Phillips, M. I. (1998) Injection of AT₁ receptor antisense in adeno-associated virus (AAV) attenuates hypertension in the spontaneously hypertensive rat (SHR). FASEB J. 12, #522, A90, (abstr.).

Comments (Loading...)

Post comment/View all comments